VSNL1 and Alzheimer disease: To test this hypothesis, the authors compared the levels of Ng, VILIP-1, SNAP-25, and Nfl in the CSF of clinically healthy subjects enrolled at the Knight Alzheimer Disease Research Center at Washington University with the aim of identifying and validating AD biomarkers.